New Indiana CTSI funding heralds health-related research growth at Purdue

Working on research funded in part by Indiana CTSI, Jacqueline Linnes, the Marta E. Gross Associate Professor of Biomedical Engineering, is developing a low-cost, paper-based test for cervical cancer. (Purdue University photo/Charles Jischke)

WEST LAFAYETTE, Ind. – The Indiana Clinical and Translational Sciences Institute (CTSI) has successfully secured $38 million from the National Institutes of Health for the next seven years, marking the fourth consecutive grant for the statewide research enterprise.  

The Indiana CTSI was established in 2008 to accelerate clinical and translational research across the state by forming an alliance among the state’s three research universities – Indiana, Purdue and Notre Dame – along with partner health care systems, government agencies and company partners. It provides resources, education, training and funding opportunities to investigators who conduct research ranging from basic science to clinical research and community-based studies.

George Wodicka, deputy director of the Indiana CTSI and the Vincent P. Reilly Professor of Biomedical Engineering at Purdue University, said the funding is significant for the university because “it will support key initiatives in areas such as wearable health devices and personalized nutrition that decentralize clinical trials and expand care across Indiana and beyond.”

“Purdue University brings unique expertise and technical capabilities to the alliance in medical devices, nutrition, drug discovery, and community health partnerships and Extension services,” said Thomas Sors, assistant director of the Purdue Institute of Inflammation, Immunology and Infectious Disease and director of operations for the Indiana CTSI at Purdue.

Sors also said that the grant will enable greater impact throughout the state through increased clinical trials and product translation.

The Indiana CTSI offers a wide range of specialized research programs at Purdue. They include:

  • MTAP, the Medical Technology Advance Program, designed to increase the success rate of clinical translation and commercialization of medical devices.
  • CHEP, Community Health Partnerships, which engages with health-related partnerships throughout Indiana.
  • CRC, the Clinical Research Center, which conducts nutritional assessment protocols for people throughout Indiana.

Through Indiana CTSI infrastructure, Purdue’s Office of Research supports various pilot funding programs that incentivize and assist investigators at all levels to develop successful external grants. 

About the Indiana Clinical and Translational Sciences Institute

The Indiana CTSI brings together the state’s brightest minds to solve Indiana’s most pressing health challenges through research. It is a statewide partnership among Indiana University, Purdue University, the University of Notre Dame and numerous life sciences businesses, government entities, and community organizations. The Indiana CTSI engages with the public at every level of research – from basic science to patient care and beyond. It has been continuously funded by multimillion-dollar grants from the National Institutes of Health since its founding in 2008.

About Purdue University

Purdue University is a top public research institution developing practical solutions to today’s toughest challenges. Ranked in each of the last five years as one of the 10 Most Innovative universities in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at

Writer/Media contact: Amy Raley,

Sources:  George Wodicka,

Thomas Sors,